000 04169nam a22004575i 4500
999 _c381909
_d381909
_x1
001 381909
003 ES-MaUEC
005 20230102121940.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 220910s2022 si | s |||| 0|eng d
020 _a9789811916229
024 7 _a10.1007/978-981-19-1622-9
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRA650.7.J3
_b2022 EB
245 0 0 _aEpidemiologic Research on Real-World Medical Data in Japan :
_bVolume 2
_cedited by Naoki Nakashima
250 _aFirst edition 2022
264 1 _aSingapore
_bSpringer Nature Singapore
_c2022
300 _a1 recurso en línea (XXIX, 120 páginas)
_b29 ilustraciones, 25 ilustraciones a color
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
490 0 _aSpringerBriefs for Data Scientists and Innovators
_x2520-1921 ;
_v2
505 0 _aPart 1: Clinical Pathway -- Chapter 1. Real World Medical Data Clinical Pathway in Japan -- Chapter 2. Medical process analysis by using all-variance type outcome-oriented electronic clinical pathway data -Exploratory extracting critical indicator -- Chapter 3. Information and Data standard development for Clinical Pathways -- Part 2: Standard Code Mapping and Data Quality -- Chapter 4. Japan Laboratory Code (JLAC) 10 -- Chapter 5. ICD-10 and ICD-11 in Japan -- Chapter 6. Standard codes for prescribing drugs use multiple code systems depending on their purpose -- Chapter 7. Data Quality Governance Experience at the MID-NET Project -- Part 3: Phenotyping -- Chapter 8. Phenotyping in Japan -- Chapter 9. Phenotyping of Administrative Claims Data -- Chapter 10. Phenotyping study using MID-NET database -- Chapter 11. Integration of phenotyping algorithms in Japan -- Part 4: Data Analysis on Real World Data -- Chapter 12. Analysis on Real-World Data: An Overview -- Chapter 13. Problems in Japanese real-world medical data analyses -- Part 5: Ethical Issues of Data Secondary Use in Japan -- Chapter 14. Ethical, Legal, and Social Issues Pertaining to the Use of Real-world Health Data in Japan -- Chapter 15. The Next-Generation Medical Infrastructure Law.
520 _aThis book analyzes the development of medical big data projects in Japan. Japan is experiencing unprecedented population aging, and labor productivity has decreased accordingly. Big data analysis of the Japanese medical real-world database (RWD) has the potential to tackle this issue. To allow readers to gain an understanding of Japanese medical big data analysis, the book discusses the original Japanese system that generates medical RWDs in the hospital medical records system, the nationwide standardized health checkup system, and the public medical insurance system in Japan. After introducing four major big data projects in the healthcare-medical field in Japan, the book explains the importance of creating information standards to maintain data quality and to analyze medical big data. It enables readers to analyze which standards are installed in which RWDs, how the standards are maintained, and which issues are prevalent in Japan. This book also describes the ethical processes involved in big data projects involving medical RWDs in Japan.
988 _aSpringer_Medicine_2022
650 7 _2embne
_9138405
_aEpidemiología
_zJapón
650 7 _2embne
_9421154
_aInformática médica
_zJapón
700 1 _aNakashima, Naoki
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9789811916212
776 0 8 _iPrinted edition:
_z9789811916236
830 0 _aSpringerBriefs for Data Scientists and Innovators,
_x2520-1921 ;
_v2
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-19-1622-9
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b09/2022
_dz
_eIG
_zSI